Health Decisions Provides Response to Inquiries Regarding the Business Impact of the December 8th Tragic Accident

Durham, North Carolina--As we mourn the loss of our CEO, Michael Rosenberg, MD, MPH, and five others in Maryland Monday, December 8, Health Decisions' day-to-day site, clinical and business operations continue without interruption.

Over the past three years, while Dr. Rosenberg focused on building the Company's infrastructure, he had transitioned day-to-day management and operations to a Corporate Executive Team, who rely upon a supporting advisory board and directors that manage each function of the business.

We are providing this business update in hopes that the focus of the tragedy can return to supporting those who were impacted.

Patrick Phillips, Vice President, Clinical Affairs

 

Suggested Articles

Genesis Drug Discovery & Development has bought up New England Discovery Partners as it looks to boost its synthetic and medicinal chemistry.

Sanofi plans to incorporate its real-world data platform with Aetion’s analytics system to better develop studies for regulatory decision-making.

Major CRO player Pharmaceutical Product Development is set to go back on the public markets after announcing its IPO plans.